DUBLIN--(BUSINESS WIRE)--Jun 13, 2018--The "Single-Cell Analysis - Global Market Outlook (2017-2023)" report has been added to ResearchAndMarkets.com's offering.

The Global Single-Cell Analysis Market accounted for $1.46 billion in 2016 and is expected to reach $5.08 billion by 2023 with a CAGR of 19.5%.

Factors such as growing occurrence of chronic and infectious disorder, increasing implementation of single cell analysis devices and rising government funding for cell-based research are propelling the growth of the market. However, high initial investment is hampering the market. Development in stem cell research and amalgamation of microfluidics in single-cell analysis provides ample opportunities for the market growth.

North America is anticipated to account for the biggest market share because of increase in government support for R&D and establishment of pharmaceutical and biotechnology companies. APAC is expected to grow at the highest CAGR during the forecast period owing to its increasing healthcare expenditure and rising demand for genetic analysis.

Segments Covered

Cell Types

Animal Cells Human Cells Microbial Cells

Products

Instruments Consumables

Techniques

Next-Generation Sequencing Flow Cytometry Microscopy Mass Spectrometry Polymerase Chain Reaction Other Techniques

End Users

Biotechnology and Pharmaceutical Companies Cell Banks and IVF Centers Academic & Research Laboratories Hospitals and Diagnostic Laboratories

Applications

Medical Applications Research Applications

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Single-Cell Analysis Market, By Cell Type

6 Global Single-Cell Analysis Market, By Product

7 Global Single-Cell Analysis Market, By Technique

8 Global Single-Cell Analysis Market, By End-User

9 Global Single-Cell Analysis Market, By Application

10 Global Single-Cell Analysis Market, By Geography

11 Key Developments

12 Company Profiling

Thermo Fisher Scientific, Inc. Beckman Coulter, Inc. Qiagen N.V. GE Healthcare Fluidigm Corporation Merck KGaA Bio-Rad Laboratories, Inc. Illumina, Inc. Agilent Technologies Becton, Dickinson and Company WaferGen Bio-systems, Inc. Eppendorf AG NuGEN Technologies, Inc. 10x Genomics Johnson & Johnson

For more information about this report visit https://www.researchandmarkets.com/research/fglqmx/global_5_08bn?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180613005531/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/13/2018 07:32 AM/DISC: 06/13/2018 07:32 AM

http://www.businesswire.com/news/home/20180613005531/en